The South Carolina Heart Valve Center
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) is a new treatment option for patients with severe aortic stenosis (narrowing of the aorta) who are not ideal candidates for traditional open heart surgery. Currently, the TAVR procedure is FDA approved for patients with aortic stenosis who are too sick or have too many risk factors to undergo traditional, open aortic valve replacement surgery. This procedure received FDA approval in November 2011 and MUSC became the first hospital in South Carolina to perform TAVR in the spring of 2012.